Flora Growth Completes Construction Of Laboratory, Specializing In Prescription Cannabis Formulations

Flora Growth Corp. (NASDAQ:FLGC) announced the completion of its new laboratory, specializing in the manufacturing of compound formulations utilizing cannabis derivatives and traditional master formulas. Located in Bogota, Colombia, Flora Lab 4 will become part of Flora’s group of laboratories including existing labs that produce cosmetics, phytotherapeutic products, dietary supplements, and cannabis extraction and transformation.

“The completion of Flora Lab 4 is an important step in Flora Growth’s progress toward commercializing medicinal cannabis. This lab is built to produce prescription grade medications and manufacture cannabis-based formulations,” stated Luis Merchan, chairman and CEO of Flora Growth Corp. “We look forward to giving access to prescribing doctors in Colombia and more importantly, to patients who stand to benefit from safe, high quality medicinal cannabis.”

The new laboratory will offer design, development, and manufacturing services of master formulas for third parties, making available to clients its knowledge of cannabis, its professional team, and modern facilities to promote growth in the sector.

Flora Lab 4’s initial prescription formulations have been developed to support the treatment of specific ailments such as social anxiety and acne. The laboratory is waiting for a regulatory inspection by INVIMA to complete certification. Once this step is complete, the new formulations will be available to prescribing doctors in Colombia.

Get your daily dose of cannabis news on Benzinga Cannabis. Don’t miss out on any important developments in the industry.

Photo by Richard T on Unsplash

Flora Growth Exports High CBD Dried Cannabis Flower Into New International Markets

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.